← Open Payments lookup

ERNST RENONDEAU: Open Payments

NPI 1134714546 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,041 in 135 payments from 9 companies in 2025. Trend: 2023 $2,037 · 2024 $2,149 · 2025 $2,041

Food & beverage: $2,041
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.56$661
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$356
Alkermes, Inc.13$324
E.R. Squibb & Sons, L.L.C.13$198
ABBVIE INC.22$197
Neurocrine BioSciences, Inc.8$145
Otsuka America Pharmaceutical, Inc.3$69
Janssen Pharmaceuticals, Inc3$57
Indivior Inc.2$34

Products named: AUSTEDO XR, CAPLYTA, ARISTADA, UZEDY, COBENFY, VRAYLAR, INGREZZA, REXULTI.

Industry payments across NJ — which companies pay providers there.